Biotin-Linked Monoclonal Antibody to Suppression Of Tumorigenicity 14 (ST14)
  • Biotin-Linked Monoclonal Antibody to Suppression Of Tumorigenicity 14 (ST14)

Biotin-Linked Monoclonal Antibody to Suppression Of Tumorigenicity 14 (ST14)

Ref: CC-LAP657Hu72-100 ul
100 ul

Información del producto

Biotin-Linked Monoclonal Antibody to Suppression Of Tumorigenicity 14 (ST14)

Click here for manual in PDF

Información adicional
Size 100 ul
Applications ICC.
IHC
WB
Concentration 1mg/mL
Detection Range Cloud Clone
Sensitivity 100 ul
Research Area Tumor immunity
Immunogen MAP657Hu21-Monoclonal Antibody to Suppression Of Tumorigenicity 14 (ST14)
Organism species Homo sapiens (Human)
Alternative Names Epithin
HAI
MT-SP1
Matriptase
Membrane-type serine protease 1
PRSS14
Prostamin
SNC19
Serine protease 14
TADG15
Tumor-associated differentially-expressed gene 15
Item Name Suppression Of Tumorigenicity 14
Assay Length Tumor immunity
Sample Type WB
Host CHO
Assay procedure summary Western blotting: 0.5-2ug/ml
Immunocytochemistry in formalin fixed cells: 5-20ug/ml
Immunohistochemistry in formalin fixed frozen section: 5-20ug/ml
Immunohistochemistry in paraffin section: 5-20ug/ml
Enzyme-linked Immunosorbent Assay: 0.0
UniProt ID AAH30532.1
Buffer Formulation 0.01M PBS, pH7.4, containing 0.05% Proclin-300, 50% glycerol.
Usage Western blotting: 0.5-2ug/ml
Immunocytochemistry in formalin fixed cells: 5-20ug/ml
Immunohistochemistry in formalin fixed frozen section: 5-20ug/ml
Immunohistochemistry in paraffin section: 5-20ug/ml
Enzyme-linked Immunosorbent Assay: 0.0
Tissue Source Antibody labeling

Enviar un mensaje


Biotin-Linked Monoclonal Antibody to Suppression Of Tumorigenicity 14 (ST14)

Biotin-Linked Monoclonal Antibody to Suppression Of Tumorigenicity 14 (ST14)